9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
SillaJen, Inc.
Incyte Corporation
Onward Therapeutics
Eisai Inc.
University of Maryland, Baltimore
University of Maryland, Baltimore
Takeda
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Swiss Cancer Institute
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center